Trial intelligence / Profile preview

S-Caine Peel Safety in Dermal Procedures

NCT00107835Phase 3Completed

Sponsor
ZARS Pharmaceuticals
Start
May 2005
Primary completion
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lidocaine 10% oropharyngeal spray, tetracaine in pain, sponsored by ZARS Pharmaceuticals. Started May 2005; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spraytetracaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT00107835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00107835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call